Associations Between Insulin-like Growth Factor-1 Standard Deviation Score and Overall Nutritional Parameters in Patients with Maintenance Hemodialysis: a Cross-sectional Study

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2023 Feb 28

PMID 36853448

Authors

Tingting Xing

Yao Xu

Jiaqi Li

Luona Wen

Qingdong Xu

Weifeng Liang

Pan Liang

Yun Liu

Rongshao Tan

Yan Liu

Xiaoshi Zhong

Affiliations

Soon will be listed here.

Abstract

Background: This study investigated the association between insulin-like growth factor-1 and nutritional status indicators in patients undergoing maintenance hemodialysis (MHD).

Methods: Patients undergoing MHD for > 3 months were included in this single-center cross-sectional study in March 2021. Clinical, demographic, and body mass data and blood samples were collected before the hemodialysis sessions. Serum insulin-like growth factor-1 (IGF-1) levels were measured using a radioimmunoassay, and serum IGF-1 standard deviation score (SDS) was calculated for MHD patients according to age and sex. The nutritional status of patients was assessed using serum albumin, serum prealbumin, handgrip strength, pinching strength, upper arm muscle circumference, lean body mass, phase angle, seven-point subjective global assessment (SGA) score, and geriatric nutritional risk index (GNRI). The patients were divided into groups according to tertiles of serum IGF-1 SDS levels. Spearman correlation analyses and univariate and multivariate binary logistic regression analyses were used to determine the association between serum IGF-1 SDS and nutritional status parameters.

Results: A total of 155 MHD patients (male: female = 90:65) were enrolled in the study, with a median dialysis vintage of 28.0 (11.0, 55.0) months, and an average age of 66 (65.5 ± 13.0) years. The median of IGF-1 SDS was - 0.1 (- 0.6 to 0.6). Compared to patients with higher IGF-1 SDSs, patients with lower IGF-1 SDSs had lower levels of serum ceruloplasmin (341.0 [287.5, 416.0] vs 395.0 [327.0, 451.0] vs 409.0 [349.5, 507.5], p = 0.002), serum albumin (34.7 ± 3.0 vs 37.0 ± 3.1 vs 37.8 ± 2.6, p < 0.001), serum prealbumin (270.3 [233.7, 327.8] vs 326.0 [279.3, 355.6] vs 363.0 [324.2, 398.2], p < 0.001), handgrip strength (13.8 [10.0, 20.7] vs 17.7 [10.7, 22.5] vs 23.3 [16.6, 27.8], p < 0.001), pinch strength (4.6 [3.9, 6.0] vs 4.9 (3.9, 6.9) vs 6.5 [4.7, 8.7], p = 0.002), phase angle (3.3 [3.0, 3.8] vs 3.9 [3.4, 4.7] vs 4.3 [3.6, 5.2, p < 0.001), modified Creatinine Index (83.1 ± 19.7 vs 93.1 ± 23.4 vs 113.9 ± 24.3, p < 0.001), intracellular water (14.5 ± 4.4 vs 16.1 ± 4.9 vs 16.9 ± 4.4, p = 0.031), higher extracellular water (26.9 ± 5.8 vs 25.7 ± 5.5 vs 25.1 ± 3.1, p = 0.042), and higher malnutrition risk as defined by GNRI (49.0% vs 15.7% vs 11.5%, p < 0.001) and SGA (53.9% vs 23.5% vs 7.7%, p < 0.001).

Conclusions: Lower IGF-1 SDSs are independently associated with higher malnutrition risk in patients with MHD.

References

Obi Y, Qader H, Kovesdy C, Kalantar-Zadeh K . Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015; 18(3):254-62. PMC: 4506466. DOI: 10.1097/MCO.0000000000000171. View

Koppe L, Fouque D, Kalantar-Zadeh K . Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019; 10(3):479-484. PMC: 6596400. DOI: 10.1002/jcsm.12421. View

Carrero J, Thomas F, Nagy K, Arogundade F, Avesani C, Chan M . Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018; 28(6):380-392. DOI: 10.1053/j.jrn.2018.08.006. View

Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L . A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2007; 73(4):391-8. DOI: 10.1038/sj.ki.5002585. View

Takahashi H, Inoue K, Shimizu K, Hiraga K, Takahashi E, Otaki K . Comparison of Nutritional Risk Scores for Predicting Mortality in Japanese Chronic Hemodialysis Patients. J Ren Nutr. 2017; 27(3):201-206. DOI: 10.1053/j.jrn.2016.12.005. View

Gungor O, Ulu S, Hasbal N, Anker S, Kalantar-Zadeh K . Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?. J Cachexia Sarcopenia Muscle. 2021; 12(6):1380-1392. PMC: 8718043. DOI: 10.1002/jcsm.12839. View

Besbas N, Ozaltin F, Coskun T, Ozalp S, Saatci U, Bakkaloglu A . Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr Nephrol. 2003; 18(12):1255-9. DOI: 10.1007/s00467-003-1264-4. View

Wang X, Tian F, Sun H, Zhang L, Gao X, Huang Y . Insulin-like growth factor-1 as a nutritional monitoring factor in patients with chronic intestinal failure. Clin Nutr. 2018; 38(4):1737-1744. DOI: 10.1016/j.clnu.2018.07.031. View

Jia T, Gama Axelsson T, Heimburger O, Barany P, Lindholm B, Stenvinkel P . IGF-1 and survival in ESRD. Clin J Am Soc Nephrol. 2013; 9(1):120-7. PMC: 3878692. DOI: 10.2215/CJN.02470213. View

10.

Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N . Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J. 2012; 59(9):771-80. DOI: 10.1507/endocrj.ej12-0110. View

11.

Cuppari L, Meireles M, Ramos C, Kamimura M . Subjective global assessment for the diagnosis of protein-energy wasting in nondialysis-dependent chronic kidney disease patients. J Ren Nutr. 2014; 24(6):385-9. DOI: 10.1053/j.jrn.2014.05.004. View

12.

Shah B, Sucher K, Hollenbeck C . Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract. 2006; 21(3):312-9. DOI: 10.1177/0115426506021003312. View

13.

Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S . Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008; 87(1):106-13. DOI: 10.1093/ajcn/87.1.106. View

14.

Canaud B, Granger Vallee A, Molinari N, Chenine L, Leray-Moragues H, Rodriguez A . Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PLoS One. 2014; 9(3):e93286. PMC: 3966881. DOI: 10.1371/journal.pone.0093286. View

15.

Frisancho A . Triceps skin fold and upper arm muscle size norms for assessment of nutrition status. Am J Clin Nutr. 1974; 27(10):1052-8. DOI: 10.1093/ajcn/27.8.1052. View

16.

Haywood N, A Slater T, Matthews C, Wheatcroft S . The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes. Mol Metab. 2018; 19:86-96. PMC: 6323188. DOI: 10.1016/j.molmet.2018.10.008. View

17.

Tonshoff B, Kiepe D, Ciarmatori S . Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol. 2005; 20(3):279-89. DOI: 10.1007/s00467-005-1821-0. View

18.

Lofqvist C, Andersson E, Gelander L, Rosberg S, Blum W, Wikland K . Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab. 2001; 86(12):5870-6. DOI: 10.1210/jcem.86.12.8117. View

19.

Johannsson G, Ahlmen J . End-stage renal disease: endocrine aspects of treatment. Growth Horm IGF Res. 2003; 13 Suppl A:S94-S101. DOI: 10.1016/s1096-6374(03)00063-7. View

20.

Mori K . Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis. Nutrients. 2021; 13(5). PMC: 8147474. DOI: 10.3390/nu13051538. View